Form 4: Equillium Inc. Director Acquires Stock Options
SEC Form 4 Filing
Charles Douglas McDermott, a director of Equillium, Inc., acquired stock options for 20,000 shares on May 22, 2024.
Summary
- On May 22, 2024, Charles Douglas McDermott, a director of Equillium, Inc., acquired stock options.
- The options grant the right to buy 20,000 shares of Equillium's common stock at an exercise price of $1.43.
- The options vest in twelve equal monthly installments starting from the grant date and will be fully vested by the date of the Issuer's annual meeting of stockholders following the grant date.
- The options expire on May 22, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating a director's acquisition of stock options, which can be seen as a mild positive but doesn't provide strong bullish or bearish signals.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Date of the stock option grant and transaction. |
| 05/23/2024 | Date of signature on the Form 4 filing. |
| 05/22/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.